Document Detail


Serum cystatin C and the incidence of hypertension in type 1 diabetes mellitus.
MedLine Citation:
PMID:  20885369     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
BACKGROUND: Serum cystatin has been shown to be associated with hypertension in the general population. Little is known on the relationship of serum cystatin C with the long-term hypertension incidence in persons with diabetes. We examined the association of serum cystatin C with the incidence of hypertension over a 15-year period in people with type 1 diabetes mellitus.
METHODS: The 15-year cumulative incidence of hypertension was measured in Wisconsin Epidemiologic Study of Diabetic Retinopathy participants. Hypertension was defined as a systolic blood pressure (BP) of ≥140 mm Hg and/or a diastolic BP of ≥90 mm Hg and/or history of use of antihypertensive treatment. The relation of cystatin C and other risk factors to hypertension incidence was determined with generalized linear modeling with the complementary log-log link function.
RESULTS: After controlling for age, gender, diabetes duration, body mass index (BMI), glycosylated hemoglobin, and baseline systolic and diastolic BP, the baseline serum cystatin C was associated with the 15-year cumulative incidence of hypertension (hazard ratio (HR) per mg/l of cystatin C: 3.43, and 95% confidence interval: 1.36, 8.63).
CONCLUSIONS: These findings show a relationship of serum cystatin C with the incidence of hypertension in type 1 diabetes mellitus. The underlying biological processes remain to be determined.
Authors:
Karine Sahakyan; Barbara E K Klein; Kristine E Lee; Michael Y Tsai; Ronald Klein
Related Documents :
2182759 - Elevated fibrinogen and plasminogen activator inhibitor (pai-1) in hypertension are rel...
3315399 - Impaired insulin-mediated erythrocyte magnesium accumulation in essential hypertension.
5761829 - Significance of electrocardiographic changes in hypertension.
10523469 - The treatment of hypertension and dyslipidemia in diabetes mellitus.
20920079 - Relationship between diabetes mellitus, hypertension and obesity, and health-related qu...
18374529 - Antihypertensive effect of total flavones extracted from seed residues of hippophae rha...
8580569 - Central diabetes insipidus caused by pituitary metastasis of lung cancer.
1719559 - Augmentation of synthesis of plasminogen activator inhibitor type 1 by insulin and insu...
4393739 - Posttranscriptional control of tyrosine aminotransferase synthesis by insulin.
Publication Detail:
Type:  Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't     Date:  2010-09-30
Journal Detail:
Title:  American journal of hypertension     Volume:  24     ISSN:  1941-7225     ISO Abbreviation:  Am. J. Hypertens.     Publication Date:  2011 Jan 
Date Detail:
Created Date:  2010-12-17     Completed Date:  2011-02-11     Revised Date:  2012-01-04    
Medline Journal Info:
Nlm Unique ID:  8803676     Medline TA:  Am J Hypertens     Country:  United States    
Other Details:
Languages:  eng     Pagination:  59-63     Citation Subset:  IM    
Affiliation:
Department of Ophthalmology and Visual Sciences, University of Wisconsin School of Medicine and Public Health, Madison, USA. sahakyan@epi.ophth.wisc.edu
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Adult
Body Mass Index
Cystatin C / blood*
Diabetes Mellitus, Type 1 / blood*,  complications
Female
Glomerular Filtration Rate
Humans
Hypertension / epidemiology*
Incidence
Male
Middle Aged
Grant Support
ID/Acronym/Agency:
DK073217/DK/NIDDK NIH HHS; EY016379/EY/NEI NIH HHS; R01 DK073217-03/DK/NIDDK NIH HHS; R01 EY016379-04/EY/NEI NIH HHS
Chemical
Reg. No./Substance:
0/Cystatin C

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Early abnormalities of cardiovascular structure and function in middle-aged Korean adults with prehy...
Next Document:  Accuracy of anthropometric indexes of obesity to predict diabetes mellitus type 2 among men and wome...